Sanofi (SNY)
NASDAQ: SNY
· Real-Time Price · USD
49.38
-0.29 (-0.58%)
At close: Jun 16, 2025, 3:59 PM
50.00
1.26%
After-hours: Jun 16, 2025, 07:53 PM EDT
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2018 |
|---|---|---|---|---|
| Europe Revenue | 10.39B | 10B | 9.76B | 2.32B |
| Europe Revenue Growth | +3.93% | +2.46% | +320.83% | n/a |
| France Revenue | 2.38B | n/a | n/a | 12.19B |
| France Revenue Growth | n/a | n/a | n/a | n/a |
| North America Revenue | 19.22B | n/a | n/a | n/a |
| North America Revenue Growth | n/a | n/a | n/a | n/a |
| Reportable Geographical Zones Revenue | 43.07B | n/a | n/a | n/a |
| Reportable Geographical Zones Revenue Growth | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.22B | 1.24B | 2.68B | 2.69B | 2.6B | 5.51B | 2.58B | 2.58B | 2.61B | 2.94B | 2.64B | 2.6B | 2.38B | 2.8B | 2.27B | 2.36B | 2.19B | 2.66B | 2.18B | 2.3B | 2.34B | 2.82B | 2.31B | 2.5B | 2.38B | 2.81B | 2.31B | 2.54B | 2.31B | 2.8B | 2.31B | 2.62B | 2.48B | 2.72B | 2.27B | 2.46B | 2.21B | 1.95B | 2.46B | 2.27B | 2.44B |
| Selling, General, and Administrative Revenue Growth | +78.90% | -53.67% | -0.52% | +3.45% | -52.72% | +113.65% | +0.16% | -1.23% | -11.39% | +11.27% | +1.69% | +9.29% | -15.10% | +23.60% | -3.90% | +7.52% | -17.49% | +21.86% | -5.01% | -1.92% | -17.07% | +22.20% | -7.71% | +5.39% | -15.29% | +21.43% | -9.16% | +9.99% | -17.55% | +21.18% | -11.78% | +5.85% | -8.80% | +19.48% | -7.37% | +10.99% | +13.49% | -20.80% | +8.27% | -6.77% | n/a |
| Research and Development Revenue | 1.81B | 2.12B | 1.85B | 1.72B | 1.72B | 3.54B | 1.66B | 1.63B | 1.56B | 1.82B | 1.74B | 1.72B | 1.49B | 1.59B | 1.44B | 1.4B | 1.27B | 1.52B | 1.32B | 1.35B | 1.34B | 2.53B | 1.36B | 1.59B | 1.39B | 2.13B | 1.46B | 1.48B | 1.28B | 1.56B | 1.34B | 1.36B | 1.31B | 1.5B | 1.22B | 1.28B | 1.24B | 1.24B | 1.35B | 1.21B | 1.2B |
| Research and Development Revenue Growth | -14.68% | +14.42% | +7.86% | -0.12% | -51.37% | +112.57% | +2.02% | +4.29% | -14.26% | +5.01% | +0.70% | +15.78% | -6.12% | +9.91% | +3.29% | +10.35% | -16.55% | +14.84% | -2.29% | +0.90% | -47.10% | +86.25% | -14.30% | +14.58% | -35.10% | +46.06% | -0.95% | +15.23% | -17.90% | +16.26% | -1.25% | +3.74% | -12.44% | +22.44% | -4.53% | +3.56% | -0.24% | -8.63% | +12.35% | +0.58% | n/a |